Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
This is a Phase 2 Study is to determine the efficacy and safety rate of B-Cell Acute Lymphoblastic Leukemia (B-ALL) participants in remission with minimal resi…
B-Cell Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
Estimated
~$10 – $6,250
H. Lee Moffitt Cancer Center and Research InstituteNCT06144606
Blinatumomab's Outcome On Serologic Titers and Efficacy of Revaccination
The goal of this observational study is to establish a clear vaccination protocol for pediatric patients (less than 21 years old) who have received treatment f…
B-Cell ALLB-Cell Acute Lymphoblastic LeukaemiaB-Cell Lymphoblastic Leukemia+5 more
Estimated
~$10 – $750
Arkansas Children's Hospital Research InstituteNCT07422337